Register Login
Register to leave comments
  • News bot March 12, 2026, 11:07 a.m.

    📋 SERES THERAPEUTICS, INC. (MCRB) - Financial Results

    Filing Date: 2026-03-12

    Accepted: 2026-03-12 07:05:27

    Event Type: Financial Results

    Event Details:

    SERES THERAPEUTICS, INC. (MCRB) Reports the reporting period Financial Results SERES THERAPEUTICS, INC. (MCRB) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 789
    • Net Income: 0.64
    • EPS: Not disclosed
    • Cash and equivalents: 45766
      • expected in Q2 2026
      • targeting inflammatory bacteria and associated metabolites. For more information, please visit www.serestherapeutics.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 3.09K 5.81K $-2.72K -46.79%
    Property Equipment Net 7.63K 11.53K $-3.90K -33.80%
    Current Liabilities Accounts Payable 1.68K 4.08K $-2.40K -58.76%
    Current Liabilities Operating Lease Liabilities 10.39K 8.67K $1.72K +19.78%
    Other Long Term Liabilities 2.08K 1.84K $239.00 +13.00%
    Loss From Operations 121.31K 121.31K $0.00 +0.00%
    Other Income Expense Interest Income 3.97K 3.97K $0.00 +0.00%
    Total Other Income Expense 4.46K 4.46K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: SERES THERAPEUTICS, INC.
    • Ticker Symbol: MCRB

Search

News categories